BIO.News Newsletter

Happy August. We take a deep dive into the emotional testimonies at last week’s FTC hearing on the impact of PBMs, and why it’s more important than ever to get your seasonal flu shot. Get the details below, plus more news you need to know this week. (670 words, 3 minutes, 21 seconds)

A new week, and more reasons to support AMR R&D and the Pediatric Disease Priority Review Voucher (PPRV) program. (752 words, 3 minutes, 45 seconds)

We’re back with a recap of yesterday’s House Oversight hearing with the three largest PBMs, what BIO’s saying about the Farm Bill, and more. (730 words, 3 minutes, 39 seconds)

What a week. We start a new one with a look at the latest news on avian flu and AMR, plus what’s ahead in Washington (including a PBM hearing tomorrow). (805 words, 4 minutes, 1 second)

Back so soon? We have a lot to share, with FDA’s announcement of a Rare Disease Innovation Hub plus more benefits of COVID-19 vaccines and the latest data on global childhood vaccination rates. (528 words, 2 minutes, 38 seconds)P.S. It’s not too late to complete the 3-minute reader survey and weigh in on BIO’s media content and communications! 

While we get ready to evolve to a new format for the rest of the summer, we feel like it’s a good day to check in on COVID-19 and how far we’ve come—thanks to the biotech industry’s efforts we’ve been covering for 4+ years. Plus, a proposed rule change from CMS represents a positive step toward better patient access to cutting-edge Alzheimer’s treatments. (624 words, 3 minutes, 7 seconds)

Good Day BIO is evolving. Over the summer, Bio.News will bring you a weekly digest every Monday at 10 A.M. ET, plus breaking news alerts as needed. This transition period will allow us to analyze feedback and analytics and develop even better communications to meet your needs. This week: BIO Board member Frank Watanabe's testimony at a House hearing, an exclusive interview with Sen. Richard Burr on the legacy of Project BioShield, the latest on bird flu and PBMs, and how you can follow the RNC,…

We have details on BIO’s comments on a U.S. Patent and Trademark Office proposal that would harm the patent system—plus, more groundbreaking companies featured at the NIH Innovation Zone at BIO 2024 and how to nominate a leader for the California Life Sciences Pantheon Awards. Don’t forget to take our reader survey! (623 words, 3 minutes, 6 seconds)

At long last, the FTC released an interim report on PBMs—and the findings are not surprising. We have details, plus more about the winners of BIO’s 2024 Agri-Biotechnology Awards. Don’t forget to take our reader survey! (523 words, 2 minutes, 36 seconds)

Today, we have news on Boehringer Ingelheim’s new biomass power plant and the expanding range of lone star ticks—plus, how you can weigh in on what’s next for BIO’s communications products. (731 words, 3 minutes, 39 seconds)